Item 7.01 Regulation FD Disclosure.
On September 15, 2022, Microbot Medical Inc. (the “Company”) issued a press
release announcing that Vincent Vidal, M.D., PhD, has joined its Scientific
Advisory Board (SAB).
The press release, which is furnished as Exhibit 99.1 to this Current Report on
Form 8-K, is incorporated herein by reference. The information in this report
(including Exhibit 99.1) is being furnished pursuant to Item 7.01 and shall not
be deemed to be “filed” for the purposes of Section 18 of the Securities
Exchange Act of 1934, as amended, or otherwise subject to the liabilities of
that section. This report will not be deemed an admission as to the materiality
of any information herein (including Exhibit 99.1).
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
Exhibit
Number Description
99.1 Press Release
104 Cover Page Interactive Data File (embedded within the Inline XBRL
document)
© Edgar Online, source Glimpses
postbrexitcompliance.com 